220
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Intestinal epithelial damage due to herbal compounds – an in vitro study

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 247-255 | Received 04 Aug 2021, Accepted 18 Dec 2021, Published online: 03 Jan 2022

References

  • Born, S.L., Hu, J.K., and Lehman-McKeeman, L.D., 2000. O-hydroxyphenylacetaldehyde is a hepatotoxic metabolite of coumarin. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 28 (2), 218–223.
  • Byard, R.W., 2010. A review of the potential forensic significance of traditional herbal medicines. Journal of Forensic Sciences, 55 (1), 89–92.
  • Byard, R.W., et al., 2017. What risks do herbal products pose to the Australian community? The Medical Journal of Australia, 206 (2), 86–90.
  • Chang, M., et al., 2012. Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine. PLoS One, 7 (6), e40087.
  • Chen, Y.-L., et al., 2019. Systems pharmacology approach reveals protective mechanisms of Jian-Pi Qing-Chang decoction on ulcerative colitis. World J Gastroenterol, 25 (21), 2603–2622.
  • Chow, H.C., et al., 2019. Literature review of traditional Chinese medicine herbs-induced liver injury from an oncological perspective with RUCAM. Integrative Cancer Therapies, 18, 1534735419869479.
  • Coghlan, M.L., et al., 2015. Combined DNA, toxicological and heavy metal analyses provides an auditing toolkit to improve pharmacovigilance of traditional Chinese medicine (TCM). Scientific Reports, 5, 17475.
  • Cox, D., O'Kennedy, R., and Thornes, R.D., 1989. The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone)). Human & Experimental Toxicology, 8 (6), 501–506.
  • Crighton, E., et al., 2019. Toxicological screening and DNA sequencing detects contamination and adulteration in regulated herbal medicines and supplements for diet, weight loss and cardiovascular health. Journal of Pharmaceutical and Biomedical Analysis, 176, 112834.
  • Dunnick, J.K., and Nyska, A., 2013. The toxicity and pathology of selected dietary herbal medicines. Toxicol Pathol, 41 (2), 374–386.
  • Egan, D., et al., 1990. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metabolism Reviews, 22 (5), 503–529.
  • Falavigna, M., et al., 2020. Impact of mucin on drug diffusion: development of straightforward in vitro method for the determination of drug diffusivity in the presence of mucin. Pharmaceutics, 12 (2), 168–113.
  • Fentem, J.H., et al., 1992. Toxicity of coumarin and various methyl derivatives in cultures of rat hepatocytes and V79 cells. Toxicology in Vitro : An International Journal Published in Association with BIBRA, 6 (1), 21–25.
  • Fernández-Aceñero, M.J., Ortega Medina, L., and Maroto, M., 2019. Herbal drugs: friend or foe? Journal of Clinical and Experimental Hepatology, 9 (3), 409–411.
  • Ge, Y., et al., 2019. The tissue distribution of four major coumarins after oral administration of Angelicae pubescentis radix extract to rats using ultra-high-performance liquid chromatography. Evidence-Based Complementary and Alternative Medicine : eCAM, 2019, 2365697–2365698.
  • Gerets, H.H.J., et al., 2012. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biology and Toxicology, 28 (2), 69–87.
  • Gilbert, J.D., et al., 2014. Lethal hepatocellular necrosis associated with herbal polypharmacy in a patient with chronic hepatitis B infection. Forensic Science International, 241, 138–140.
  • Guo, J., and Xu, S., 2021. Astragaloside IV suppresses histamine-induced inflammatory factors and mucin 5 subtype AC overproduction in nasal epithelial cells via regulation of inflammation-related genes. Bioengineered, 12 (1), 6045–6056.
  • He, S., et al., 2019. Herb-induced liver injury: phylogenetic relationship, structure-toxicity relationship, and herb-ingredient network analysis. International Journal of Molecular Sciences, 20 (15), 3633.
  • Hoban, C.L., et al., 2018. Adulterants and contaminants in psychotropic herbal medicines detected with mass spectrometry and next-generation DNA sequencing. Pharmaceutical Medicine, 32 (6), 429–444.
  • Hu, Z., et al., 2005. Herb-drug interactions: a literature review. Drugs, 65 (9), 1239–1282.
  • Lacy, A., and O’Kennedy, R., 2004. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Current Pharmaceutical Design, 10 (30), 3797–3811.
  • Laine, J.E., et al., 2009. Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 39 (1), 11–21.
  • Lau, C., et al., 2013. Effect of Chinese herbs on CYP3A4 activity and expression in vitro. Journal of Ethnopharmacology, 149 (2), 543–549.
  • Loprinzi, C.L., Sloan, J., and Kugler, J., 1997. Coumarin-induced hepatotoxicity. Journal of Clinical Oncology : official Journal of the American Society of Clinical Oncology, 15 (9), 3167–3168.
  • Matos, M.J., Santana, L., Uriarte, E. & Orlando, A. (2015). Coumarins – an important class of phytochemicals. In: V. Rao, L. Rao, eds. Phytochemicals – isolation, characterisation and role in human health. London, United Kingdom: IntechOpen. https://dx.doi.org/10.5772/59982
  • Monostory, K., Hazai, E., and Vereczkey, L., 2004. Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chemico-Biological Interactions, 147 (3), 331–340.
  • Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65 (1-2), 55–63.
  • Sambuy, Y., et al., 2005. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics . Cell Biology and Toxicology, 21 (1), 1–26.
  • Shan, W., et al., 2012. Inhibitory effects of astragaloside IV on cytochrome P450 enzyme of rat liver microsomes. Zhongguo Zhong Yao za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica, 37 (1), 85–88.
  • Song, J., et al., 2014. Pharmacokinetic interaction of astragaloside IV with atractylenolide I and prim-O-glucosylcimifugin in male Sprague Dawley rats. Planta Medica, 80 (2-3), 187–192.
  • Stefanachi, A., et al., 2018. Coumarin: a natural, privileged and versatile scaffold for bioactive compounds. Molecules, 23 (2), 250.
  • Tanaka, Y., et al., 2016. Relationship between coumarin-induced hepatocellular toxicity and mitochondrial function in rats. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association, 90, 1–9.
  • Thelen, K., and Dressman, J.B., 2010. Cytochrome P450-mediated metabolism in the human gut wall. Journal of Pharmacy and Pharmacology, 61 (5), 541–558.
  • Tovar, R.T., and Petzel, R.M., 2009. Herbal toxicity. Disease-a-Month : DM, 55 (10), 592–641.
  • Van Wyk, B.-E., and Wink, M., 2017. Medicinal Plants of the World. 2nd ed. Pretoria: Briza Publications.
  • Wink, M., 2015. Modes of action of herbal medicines and plant secondary metabolites. Medicines (Basel, Switzerland), 2 (3), 251–286.
  • Xie, F., Ding, X., and Zhang, Q.Y., 2016. An update on the role of intestinal cytochrome P450 enzymes in drug disposition. Acta Pharmaceutica Sinica. B, 6 (5), 374–383.
  • Yu, J., et al., 2018. Gancao-Gansui combination impacts gut microbiota diversity and related metabolic functions. Journal of Ethnopharmacology, 214, 71–82.
  • Yu, J., et al., 2019. Health risk of Licorice-Yuanhua combination through induction of colonic H2S metabolism. Journal of Ethnopharmacology, 236, 136–146.
  • Zhong, Y., et al., 2013. Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases. Kidney International, 84 (6), 1108–1118.
  • Zhou, M., et al., 2017. Recent pharmaceutical evidence on the compatibility rationality of traditional Chinese medicine. Journal of Ethnopharmacology, 206, 363–375.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.